Bristol Myers (NYSE: BMY) EVP gains stock as RSUs vest, pays taxes in shares
Rhea-AI Filing Summary
Cari Gallman, EVP and General Counsel of Bristol Myers Squibb, reported equity compensation activity on August 1, 2026. 1,061 restricted stock units vested in three equal installments beginning on August 1, 2024, with each unit converting into one share of common stock. 543 shares of common stock were withheld at $65.31 per share to satisfy tax obligations upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 518 shares
Net Buy
3 txns
Insider
Gallman Cari
Role
EVP, General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F3, F1 | 1,061 | $0.00 | $0.00 |
| Exercise | Common Stock, $0.10 par value F1 | 1,061 | $0.00 | $0.00 |
| Tax Withholding | Common Stock, $0.10 par value F2 | 543 | $65.31 | $35K |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock, $0.10 par value — 13,649 shares (Direct)
Footnotes (3)
- F1. These restricted stock units vested in three equal installments beginning on August 1, 2024.
- F2. Shares withheld for payment of taxes upon vesting of awards.
- F3. Each restricted stock unit converts into one share of common stock upon vesting.
Key Figures
Restricted stock units vested: 1061.0000 units
Common shares acquired from RSUs: 1061.0000 shares
Shares withheld for taxes: 543.0000 shares
+1 more
4 metrics
Restricted stock units vested
1061.0000 units
RSUs vesting and converting into common stock on August 1, 2026
Common shares acquired from RSUs
1061.0000 shares
Each restricted stock unit converts into one share of common stock upon vesting
Shares withheld for taxes
543.0000 shares
Shares withheld for payment of taxes upon vesting of awards
Tax withholding price
$65.3100 per share
Per-share value used for shares withheld to satisfy tax obligations
Key Terms
Restricted Stock Units, tax-withholding disposition, derivative security
3 terms
Restricted Stock Units financial
"security_title: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action: tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Bristol Myers Squibb (BMY) EVP Cari Gallman report in this Form 4?
Cari Gallman reported vesting of 1,061 restricted stock units on August 1, 2026, each converting into one share of common stock. This reflects equity compensation rather than an open-market purchase or sale of Bristol Myers Squibb shares.
What type of securities vested for Bristol Myers Squibb (BMY) EVP Cari Gallman?
The transaction involves restricted stock units (RSUs) that convert into common stock upon vesting. In this event, 1,061 RSUs vested and each unit converted into one share of Bristol Myers Squibb common stock as part of her compensation.
Were Cari Gallman’s Bristol Myers Squibb (BMY) transactions made under a Rule 10b5-1 plan?
The Form 4’s Rule 10b5-1 checkbox is not marked, so these transactions are not designated in the filing as being made under a Rule 10b5-1 trading plan. The disclosure characterizes them as equity award vesting and related tax withholding.